In vivo gene silencing (with siRNA) of pulmonary expression of MIP-2 versus KC results in divergent effects on hemorrhage-induced, neutrophil-mediated septic acute lung injury.
about
Lung injury after hemorrhage is age dependent: role of peroxisome proliferator-activated receptor gammaRNA interference for alpha-ENaC inhibits rat lung fluid absorption in vivoDARC on RBC limits lung injury by balancing compartmental distribution of CXC chemokines.IL6 trans-signaling promotes functional recovery of hypofunctional phagocytes through STAT3 activation during peritonitis.Elastase induces lung epithelial cell autophagy through placental growth factor: a new insight of emphysema pathogenesisIL-32, a proinflammatory cytokine in rheumatoid arthritis.Silencing airway epithelial cell-derived hepcidin exacerbates sepsis induced acute lung injury.PlGF mediates neutrophil elastase-induced airway epithelial cell apoptosis and emphysemaAnimal models of acute lung injurySilencing of Fas, but not caspase-8, in lung epithelial cells ameliorates pulmonary apoptosis, inflammation, and neutrophil influx after hemorrhagic shock and sepsis.Clinical review: gene-based therapies for ALI/ARDS: where are we now?Diesel exhaust particulates exacerbate asthma-like inflammation by increasing CXC chemokines.Filamentous influenza A virus infection predisposes mice to fatal septicemia following superinfection with Streptococcus pneumoniae serotype 3The role and source of tumor necrosis factor-α in hemorrhage-induced priming for septic lung injury.Role of chemokines in the pathogenesis of acute lung injury.Fas-induced pulmonary apoptosis and inflammation during indirect acute lung injury.Stimulation of Brain AMP-Activated Protein Kinase Attenuates Inflammation and Acute Lung Injury in SepsisThe silent treatment: siRNAs as small molecule drugs.Therapeutic accessibility of caspase-mediated cell death as a key pathomechanism in indirect acute lung injuryBLOCKADE OF ENDOTHELIAL GROWTH FACTOR, ANGIOPOIETIN-2, REDUCES INDICES OF ARDS AND MORTALITY IN MICE RESULTING FROM THE DUAL-INSULTS OF HEMORRHAGIC SHOCK AND SEPSIS.Validating the use of short interfering RNA as a novel technique for cell-specific target gene knockdown in lung ischemia-reperfusion injury.Delivery systems for the direct application of siRNAs to induce RNA interference (RNAi) in vivo.Immunological research using RNA interference technology.Interfering with disease: a progress report on siRNA-based therapeutics.Applying small RNA molecules to the directed treatment of human diseases: realizing the potential.Epithelial cell apoptosis and neutrophil recruitment in acute lung injury-a unifying hypothesis? What we have learned from small interfering RNAs.Elastase induced lung epithelial cell apoptosis and emphysema through placenta growth factor.Intrapulmonary delivery of XCL1-targeting small interfering RNA in mice chronically infected with Mycobacterium tuberculosisRNAi Therapeutic Platforms for Lung Diseases.RNA interference as a potential therapeutic treatment for inflammation associated lung injury.Lipidic systems for in vivo siRNA delivery.siRNA therapeutics in the treatment of diseases.'Smart' non-viral delivery systems for targeted delivery of RNAi to the lungs.Growth factors and cytokines in acute lung injury.Acute lung injury and pulmonary vascular permeability: use of transgenic models.The mercurial nature of neutrophils: still an enigma in ARDS?Novel RNA interference-based therapies for sepsis.Platelet Activating Factor Receptor Activation Improves siRNA Uptake and RNAi Responses in Well-differentiated Airway Epithelia.Clinical translation of RNAi-based treatments for respiratory diseases.Local tissue expression of the cell death ligand, fas ligand, plays a central role in the development of extrapulmonary acute lung injury.
P2860
Q24650570-6CA2203B-C621-47FD-9144-28EA0EEC20CFQ28572413-B7FEE257-1DE0-4BFE-9CBD-A1DA51C9C0A0Q30435972-D53CFC0C-718B-4399-AA58-1096F3B4F687Q34348389-8DCDB7E2-B33B-4801-AFE8-8D76D5198D41Q34388763-EE03CFCB-F3B6-4106-827A-7A5B2FB2EABDQ34480273-066F154B-5809-4F7D-84C2-9DE24ACF0C43Q34570105-4F50F8D0-B36F-43EF-A644-42B86EEC0132Q34712632-077E28BE-CC48-4956-A803-2D090A342068Q34795312-FC91E378-9E27-40E9-BD69-ED98FCAA3BEDQ35094492-E923CEA6-37DC-4F16-B92D-99B4C0FD613DQ35558172-C05EE33C-5E15-4966-9BF6-F4900CFF7F06Q35679334-3C0A3ADF-16A3-4AEF-8152-828D74172565Q35913455-8F53BCFE-EB91-4781-AC98-250A43F26E40Q35973583-5DBE0D21-43A8-4384-B48A-C3FDE70A4C37Q35991282-50D90D61-0381-46AE-953A-EE55DCDBFB8BQ36013685-B54918C2-2E21-4F58-99AE-3F68368131A7Q36307884-940C6666-14BF-45AA-8425-A4ED3E16D77BQ36362370-6A77AD7B-2E34-4665-8524-9DB6CF9B3604Q36411370-1FEA8C09-E3F8-451C-ADBB-23870794A041Q36470562-42251875-4635-4937-A010-0B4B057BE11EQ36505492-F155EF49-363C-4A42-87FC-E445AF9DB61DQ36631534-6AF57971-B4B2-48E0-9D0A-4662F70E3BA1Q36788606-2F748A24-6FF2-4CA9-84E1-17F10EE96765Q36836598-B730B2AC-6921-4DC8-BD92-6B66E13D2C52Q37030891-4B619527-8784-419F-A7A1-5294D5638232Q37119723-4CE5C391-5380-4411-90EC-84424150C245Q37212013-1A0A040A-00B1-4360-9FCC-0B09A2D1F0EDQ37275462-19DD1444-2CB8-4169-A355-389BEDFB4DA0Q37277373-EEF17B5E-9462-4ABB-AD9B-444D09F0013FQ37349912-A222A6E4-ED8E-49B0-913D-D0E837D13C19Q37598096-8C6817AC-0107-4BF1-B522-C78CDE039182Q38074462-9D6E23E8-CDB5-42A7-A4EB-FC132895EE6BQ38074463-A4CA00BA-7660-4470-9BA7-2AE1A1AFCFB2Q38112030-1C7A5DCD-9C99-474D-9EFA-772CEEBE66DAQ38112059-32CA27BA-D8D1-4F2A-9276-ACB4CE14FC5AQ38169568-9EAC8A1A-E0A8-43F9-99CC-81983ADDF820Q38176441-4B64E57C-37A9-4A48-A461-AFF0D7C388D1Q38305769-8C82C61D-6439-4EC6-9F1F-B896463431FDQ38383297-3E54E2DC-63E1-4468-86A0-99025C7748F8Q39568045-9DEDF44C-1495-41AC-8BEF-2956DF7309B0
P2860
In vivo gene silencing (with siRNA) of pulmonary expression of MIP-2 versus KC results in divergent effects on hemorrhage-induced, neutrophil-mediated septic acute lung injury.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
In vivo gene silencing (with s ...... ated septic acute lung injury.
@en
In vivo gene silencing (with s ...... ated septic acute lung injury.
@nl
type
label
In vivo gene silencing (with s ...... ated septic acute lung injury.
@en
In vivo gene silencing (with s ...... ated septic acute lung injury.
@nl
prefLabel
In vivo gene silencing (with s ...... ated septic acute lung injury.
@en
In vivo gene silencing (with s ...... ated septic acute lung injury.
@nl
P2093
P2860
P356
P1476
In vivo gene silencing (with s ...... ated septic acute lung injury.
@en
P2093
Chun-Shiang Chung
Doreen E Wesche
Joanne L Lomas-Neira
Mario Perl
P2860
P304
P356
10.1189/JLB.1004617
P50
P577
2005-02-04T00:00:00Z